NEURAL REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025｜587 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 small extracellular vesicle derive human induce 
 pluripotent stem cell-differentiated neural progenitor 
 cell mitigate retinal ganglion cell degeneration 
 mouse model optic nerve injury 
 Abstract  
 study find transplantation neural progenitor cell npc promote survival injure neuron poor 
 integration rate high risk tumorigenicity cell transplantation limit clinical application small extracellular vesicle sev 
 contain bioactive molecule neuronal protection regeneration previous study show stem/progenitor cell-derived sevs 
 promote neuronal survival recovery neurological function neurodegenerative eye disease eye disease 
 study intravitreally transplant sev derive human induce pluripotent stem cell hipscs hipscs-differentiate npc hipsc- 
 npc mouse model optic nerve crush result intravitreally inject sev ingest retinal cell especially 
 localized ganglion cell layer treatment hipsc-npc-derived sev mitigate optic nerve crush-induced retinal ganglion cell 
 degeneration regulate retinal microenvironment inhibit excessive activation microglia component analysis reveal 
 hipsc-npc derive sev transport neuroprotective anti-inflammatory mirna cargo target cell protective effect 
 rgc optic nerve injury finding suggest sevs derive hipsc-npc promising cell-free therapeutic strategy optic 
 neuropathy 
 Key Words exosome mirna neural progenitor cell neurodegeneration neuroinflammation neuroprotection optic nerve crush optic 
 neuropathy retinal ganglion cell small extracellular vesicle 
 https://doi.org/10.4103/NRR.NRR-D-23 01414 
 Date submission August 22 2023 
 Date decision November 14 2023 
 Date acceptance December 29 2023 
 Date web publication January 31 2024 
 Introduction 
 retinal ganglion cell rgc degeneration lead irreversible 
 visual impairment common feature glaucoma 
 traumatic optic neuropathy inherit optic neuropathy 
 type optic atrophy rgc transmit visual signal 
 brain optic nerve study suggest rgc 
 regenerate injury result permanent visual 
 impairment Guo et al. 2021 Kerschensteiner 2022 Liu et 
 al. 2023 mechanism rgc degeneration complex 
 include genetic oxidative stress apoptosis hypoxia- 
 ischemia mitochondrial dysfunction gliosis inflammation 
 Ahmed et al. 2022 Fu et al. 2022 Hu et al. 2022 ju 
 Tam 2022 Rong et al. 2022 Wang et al. 2022a Newman et 
 al. 2023 Zhang et al. 2023 unfortunately limited 
 effective therapeutic strategy treatment optic 
 neuropathy explore novel treatment strategy 
 urgently need 
 human induce pluripotent stem cell hipscs invaluable 
 1state Key Laboratory Ophthalmology Optometry Visual Science Eye Hospital Wenzhou Medical University Wenzhou Zhejiang Province China 
 2national Clinical Research Center Ocular Diseases Eye Hospital Wenzhou Medical University Wenzhou Zhejiang Province China 
 Correspondence Zai-Long Chi phd zailong.chi@eye.ac.cn 
 https://orcid.org/0009 0008 9597 6546 Zai-Long Chi https://orcid.org/0009 0002 4658 2109 Tong Li 
 author contribute equally work 
 Funding study support National Natural Science Foundation China No. 82271114 Natural Science Foundation Zhejiang Province 
 China No. lz22h120001 zlc 
 cite article Li t xing HM Qian HD Gao Q Xu sl Ma H Chi ZL 2025 small extracellular vesicle derive human induce pluripotent stem 
 cell-differentiated neural progenitor cell mitigate retinal ganglion cell degeneration mouse model optic nerve injury neural Regen Res 20(2):587 597 
 graphical Abstract 
 Neuroprotective 
 mechanism 
 hipsc-npc-sevs 
 optic nerve crush 
 mouse model 
 Contents 
 Introduction 
 587 
 method  
 588 
 result 
 590 
 Discussion 
 591 
 Tong li1 hui-min xing1 hai-dong qian1 Qiao gao1 sheng-lan xu1 Hua ma1 zai-long chi1 2 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 588   ｜neural REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 tool broad application prospect therapy 
 human disease neural regeneration 
 hipsc differentiate specialized cell 
 tissue organoid specific condition ethical 
 restriction accordingly hundred clinical trial 
 hipscs human disease therapy ongoing Yokobayashi 
 et al. 2021 sugimoto et al. 2022 Wang et al. 2022b ito 
 et al. 2023 induce pluripotent stem cell (ipsc)-derived 
 mesenchymal stem cell msc promote survival 
 neuron mouse mitochondrial complex defect 
 rat model hypoxic-ischemic encephalopathy 
 Jiang et al. 2019 Huang et al. 2022 particular neural 
 progenitor cell npc neural stem cell differentiate 
 nervous system-related cell type give 
 advantage treatment neural degenerative 
 disease Liu et al. 2019 fischer et al. 2020 Baloh et al. 
 2022 ipsc-derived neural stem cells/npcs directional 
 differentiation potential neuron play important 
 role degenerative disease central nervous system 
 Strnadel et al. 2018 Huang Zhang 2019 Van Gelder et 
 al. 2022 study suggest poor rate cell 
 integration cell transplantation increase evidence 
 indicate transplant cell play role nutrition 
 microenvironment Shi et al. 2018 Gokoffski et al. 
 2020 Yuan et al. 2022 notably stem cell transplantation 
 tumorigenic immunogenic risk Goldman 2016 
 Yamanaka 2020 focus small 
 extracellular vesicle sev secrete stem 
 cell 
 sev surround phospholipid bilayer membrane 
 30–150 nm diameter contain biologically active factor 
 parent cell include rna protein lipid 
 Gandham et al. 2020 Kalluri LeBleu 2020 
 bioactive factor sev deliver recipient 
 cell act modulator pathophysiological process 
 Channon et al. 2022 Chong et al. 2022 
 sev emerge important paracrine regulator 
 local tissue act endocrine mediator 
 systemic regulation sheller-miller et al. 2019 numerous 
 study reveal stem/progenitor cell-derived 
 sev therapeutic effect disease 
 immunogenicity obvious effect Kalluri LeBleu 
 2020 ding et al. 2021 ocular neurodegenerative disease 
 ocular disease neuron survival nerve function 
 rescue stem/progenitor cell-derived sevs mead 
 Tomarev 2017 Pan et al. 2019 Cui et al. 2021 sevs 
 potential promising cell-free biological therapeutic 
 strategy neurodegenerative disease 
 study aim examine protective effect 
 sev derive hipscs npc rgc degeneration 
 explore potential mechanism hipscs directly 
 differentiate npc hipsc- npc-derived sevs 
 collect characterize type 
 sev intravitreally administer verify 
 neuroprotective effect mouse model optic nerve crush 
 onc finally set neuroprotective mirna detect 
 analyze mirna sequencing 
 method   
 Animals 
 animal experiment perform follow 
 Association Research Vision Ophthalmology 
 arvo Statement Use Animals Ophthalmic 
 Vision Research Association Research Vision 
 Ophthalmology 2021 approve Animal 
 Care Use Committee Wenzhou Medical University 
 November 27 2022 approval No. wydw2022 0735 
 c57bl/6jnifdc mouse purchase Beijing Vital River 
 Laboratory Beijing China license No. scxk jing 2021 0011 
 thy1-gfp cx3cr1-gfp mouse c57bl/6j background 
 obtain Nanjing Biomedical Research Institute 
 Nanjing University Nanjing China Shanghai Model 
 Organisms Center Shanghai China respectively mouse 
 maintain 12-hour dark/light cycle good ventilation 
 22 ° c provide standard laboratory chow water 
 animal cage activation microglia 
 affect estrogen cycle female mouse 
 male mouse aged 2–3 month 20–26 g 
 study experiment experimenter observer 
 blind group assignment outcome assessment 
 number distribution mouse experiment show 
 additional Figure 1 
 cell culture differentiation 
 cell culture differentiation perform describe 
 previous study Kirkeby et al. 2012 briefly hipsc 
 purchase sidansai Biotech Shanghai China stock 
 No. 0232 100 verify Guangzhou Institutes 
 Biomedicine Health Xue et al. 2013 cell culture 
 70–80 confluence essential 8 a1517001 Gibco 
 Billings MT usa Matrigel 356234 corning corning ny 
 USA washing sterilized phosphate-buffered saline 
 pbs medium replace neural induction medium 
 nim compose dmem/f12 1:1 Neurobasal 10888022 
 Gibco 2 b27 supplement 12587010 Gibco 1 n2 
 supplement 17502048 Gibco 1 non-essential amino 
 acid 11140050 Gibco 1 Glutamax 35050061 Gibco 
 10 µm sb431542 s1067 Selleck Houston tx usa 0.1 
 µm ldn193189 s2618 Selleck cell culture 37 ° c 
 5 co2 10 day NIM change neural 
 expansion medium compose dmem/f12 1:1 neurobasal 
 2 b27 1 n2 1 non-essential amino acid 1 
 Glutamax 10 ng/ml basic fibroblast growth factor 10014- 
 hnae SinoBio Inc. Beijing China 10 ng/ml epidermal 
 growth factor 10605-HNAE SinoBio Inc. 7 day 
 medium change supernatant collect day 
 sevs isolation characterization labeling 
 sev hipscs npc isolate serum-free cell 
 culture medium previously report Gurunathan et al. 
 2019 briefly medium collect sequentially 
 centrifuge 300 × g 10 minute 2000 × g 10 minute 
 10,000 × g 30 minute 4 ° c remove cell 
 debris filtration 0.22 μm pore filter 
 supernatant ultracentrifuge 100,000 × g 4 ° c 
 70 minute Beckman Optima xe-100 ultracentrifuge 
 Beckman Bria usa pellet obtain 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 NEURAL REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025｜589 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 size concentration purify sev determine 
 ZetaView nanoparticle tracking analysis pmx 110 Particle 
 Metrix Meerbusch Germany ultrastructure sevs 
 analyze transmission electron microscopy tem 
 H-7650 Hitachi Ltd. Tokyo Japan western blotting 
 examine protein expression alix cd9 tsg101 
 calnexin sev pellet resuspend 100 µl sterile 
 PBS 50 µl sev label pkh67 Fluorescent Cell 
 Linker Kits pkh67gl sigma-aldrich Darmstadt Germany 
 optic nerve crush sev administration 
 Mice anesthetize intraperitoneal injection 30 
 mg/kg 0.3 sodium pentobarbital p3761 sigma-aldrich 
 5 mg/kg xylazine Aladdin Shanghai China 0.5 
 proparacaine hydrochloride Alcon Laboratories Fort Worth 
 TX usa onc perform previously describe 
 Cameron et al. 2020 briefly optic nerve side 
 expose crush forceps 0203-n6-po Dumont 
 Montignez Switzerland 0.5 mm posterior lamina 
 cribrosa immediately crush 200 µg roughly 2 
 × 1011 particle hipsc- npc-sevs pbs intravitreally 
 inject 33 g Hamilton syringe Hamilton Company 
 Reno NV America ofloxacin eye ointment 14200059683 
 Shenyang Xingqi Pharmaceutical Company Shenyang China 
 normally administer surgery 
 immunofluorescence staining 
 washing three-time pbs hipscs npc fix 
 4 paraformaldehyde 15 minute permeabilize 
 PBS 0.5 Triton x-100 15 minute mouse 
 anesthetize describe sacrifice cervical 
 dislocation eyeball cryosection prepare 
 cryostat cm1950 Leica Nussloch Germany thickness 
 12 μm sample block blocking buffer PBS 
 10 bovine serum albumin 0.1 Triton x-100 1 
 hour incubate overnight 4 ° c primary antibody 
 cell incubate secondary antibody 37 ° c 
 2 hour antibody information show additional Table 
 1 washing pbs sample mount antifade 
 mounting medium 4′,6-diamidino-2-phenylindole p0131 
 Beyotime Biotechnology Shanghai China 
 western blot assay 
 concentration sev quantify Pierce BCA 
 protein assay kit 23225 Thermo Fisher Scientific Waltham 
 MA usa equal amount sample electrophorese 
 sodium dodecyl sulfate-polyacrylamide gel 10 p0052a 
 Beyotime Biotechnology transfer polyvinylidene 
 fluoride membrane ffp39 Beyotime Biotechnology 
 Blots block 5 milk 1 hour incubate 
 overnight primary antibody anti-mouse anti-rabbit 
 immunoglobulin g horseradish peroxidase-conjugated 
 antibody secondary antibody incubate 
 2 hour room temperature blot develop 
 chemiluminescence reagent 1863096 Thermo Fisher 
 Scientific image capture Invitrogen iBright 
 1500 ibright fl1500 Thermo Fisher Scientific gray value 
 band analyze imagej software version 1.8.0 
 National Institutes Health Bethesda MD usa Schneider 
 et al. 2012 antibody information show additional 
 Table 1 
 optical coherence tomography 
 optical coherence tomography oct perform 
 anesthetize animal 7 14 day post-onc picture 
 retina optic nerve head take 
 Micron iv Retinal Imaging Microscope Phoenix Research 
 Labs Pleasanton usa thickness ganglion 
 cell complex gcc consist retinal nerve fiber layer 
 ganglion cell layer inner plexiform layer 
 correspond exactly anatomical distribution rgc 
 retina Nakano et al. 2011 measure 
 imagej. 
 hematoxylin-eosin staining 
 anesthetized mouse transcardially perfuse 4 
 paraformaldehyde eye collect fix 4 
 paraformaldehyde 48 hour 4 ° c fixed eye 
 dehydrate embed paraffin specimen cut 
 5-mm thick retinal cross-section paraffin tissue section 
 dewaxed rehydrate stain hematoxylin 
 eosin c0105s Beyotime Biotechnology gcc thickness 
 measure imagej. 
 retinal flat mount analysis 
 Eyes enucleate animal sacrifice 
 fix 4 paraformaldehyde 20 minute 
 anterior portion eye remove len 
 remove fixation 4 paraformaldehyde 40 
 minute retina separate eye cut 
 quarter ophthalmic scissor retina 
 place slide mount coverslip image 
 retinal area central paracentral peripheral 
 capture average number thy1-gfp-rgcs n = 8) 
 average number grid-crossed point cx3cr1-gfp- 
 microglia n = 5 count imagej software 
 Flash visual evoke potential 
 retinal functional variation evaluate 
 electrophysiological diagnostic system reti-port21 Roland 
 Munich Germany 7 day post-onc light stimulation 
 intensity 3.0 cd·s/m2 stimulation frequency 2 Hz 
 stimulation number 100 silver electrode 
 insert anesthetize mouse skin occipital 
 bone cheek tail wave record eye 
 sev component analysis 
 total rna extract trizol reagent life 
 Technologies Carlsbad usa accord 
 manufacturer instruction rna quality check 
 perform Nanodrop2000 Thermo Fisher scientific 
 Agilent 2100 Bioanalyzer Agilent Technologies Santa 
 Clara usa rna sample concentration > 200 ng/μl 
 
 absorbance 260/280 nm a260/a280 > 1.8 < 2.2 
 a260/a230 ≥ 2.0 library construction mirna- 
 seq library construct truseq small rna Sample 
 Prep Kits Illumina San Diego usa accord 
 manufacturer instruction briefly add adapter 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 590   ｜neural REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 3 5 termination mirna reverse transcribe 
 1st strand complementary dna cdna 
 pcr amplification pcr product purify 6 
 polyacrylamide gel electrophoresis library insert 
 size determine Agilent 2100 Bioanalyzer finally 
 qualified library sequence NovaSeq 6000 
 platform Illumina 50 bp single-end read obtain 
 Adapter sequence low-quality read mirna sequence 
 remove cutadapt v3.2 National Bioinformatics 
 Infrastructure Sweden nbis Uppsala University Uppsala 
 Sweden Kechin et al. 2017 clean read map 
 late mirbase Faculty Life Sciences University 
 Manchester Manchester UK griffiths-jone et al. 2006 
 Rfam database v14.4 European Bioinformatics Institute 
 Wellcome Genome Campus Cambridge UK Kalvari et al. 
 2021 bowtie2 v2.4.5 Department Biostatistics 
 Johns Hopkins Bloomberg School Public Health Baltimore 
 MD usa Langmead Salzberg 2012 identify annotate 
 mirna sequence overlap annotate 
 sequence classify unannotated read mirdeep2 
 v2.0.1.2 Berlin Institute Medical Systems Biology bimsb 
 Hannoversche Berlin Germany Friedländer et al. 2012 
 identify novel mirna base secondary structure 
 dicer enzyme cleavage site minimum free energy index 
 Raw read count estimate mirdeep2 analyze 
 differentially express mirna demirnas stage 
 deseq2 v1.34.0 Genetics Department Biostatistics 
 Department UNC-Chapel Hill NC USA love et al. 2014 
 mirna threshold p value < 0.05 log2(fold- 
 change > 1 < –1 consider demirnas 
 gene ontology enrichment Kyoto Encyclopedia 
 Genes Genomes kegg pathway analysis 
 perform clusterprofiler v4.4.4 School Basic 
 Medical Sciences Southern Medical University Guangzhou 
 China Yu et al. 2012 enriched term kegg pathway 
 p value < 0.05 consider significant 
 statistical analysis 
 experiment repeat time 
 animal exclude analysis datum analyze 
 evaluator blind grouping student t-t 
 group one-way analysis variance group 
 follow Tukey post hoc test perform 
 GraphPad Prism version 8.0.1 Windows GraphPad 
 Software Boston ma usa www.graphpad.com difference 
 consider significant p < 0.05 
 result 
 isolation characterization sev hipscs 
 hipsc-npcs 
 obtain sev different stage stem cell hipscs 
 directly differentiate npc serum-free medium 
 established method figure 1a morphology 
 hipscs npc immunostaining specific 
 biomarker sox2 tra-1 60 hipscs pax6 
 nestin npc indicate typical characteristic figure 
 1b c hipsc-sevs npc-sevs isolate cell 
 culture supernatant ultracentrifugation method 
 Figure 1d characterization sev confirm 
 nanoparticle tracking analysis tem western blotting 
 sev show typical cup-like structure 
 tem analysis Figure 1E nanoparticle tracking analysis 
 indicate mean size sev approximately 100 nm 
 Figure 1f western blot analysis confirm 
 sev positively express representative biomarker sdcbp 
 tsg101 alix negative biomarker calnexin 
 undetectable figure 1 g 
 npc-sevs mitigate rgc degeneration optic nerve injury 
 investigate uptake sev retinal cell sevs 
 label fluorescently link pkh67 inject 
 intravitreally flat mount analysis reveal green fluorescence 
 retina 48 hour additional Figure 2a 7 day 
 additional Figure 2B injection additionally note 
 green fluorescent-labeled sev exist vitreous cavity 
 48 hour reduce day 7 additional Figure 
 2C contrast increase green fluorescent-labeled sevs 
 observe gcc layer day 7 additional Figure 
 2d immunostaining show npc-sevs internalize 
 multiple cell type 48 hour injection include rgc 
 microglia astrocyte additional Figure 2e 
 evaluate role hipsc-sevs npc-sevs 
 neuroprotection optic nerve injury sevs 
 intravitreally inject onc mouse rgc survival 
 analyze day 7 14 figure 2a oct analysis show 
 significant increase mean gcc layer thickness npc- 
 sev treatment particularly day 7 14 post-onc figure 
 2B c histopathological change optic nerve injury 
 confirm hematoxylin-eosin staining 
 npc-sev-treated retina show thicker gcc layer day 
 14 figure 2d e addition npc-sev-treated retina 
 contain cell ganglion cell layer ONC 
 day 7 14 figure 2f 
 conduct flat mount analysis retina 
 thy1-gfp transgenic mouse specific gfp labeling 
 rgc figure 3a b npc-sev treatment result great 
 rgc survival pbs hipsc-sev treatment figure 3C 
 d result suggest npc-sevs provide 
 significant rgc protection hiPSC-sEVs optic nerve 
 injury 
 npc-sevs suppress microglial activation rescue visual 
 impairment 
 Neuroinflammation important pathological process 
 neurodegenerative disease Microglia key mediator 
 progression optic neuropathy suppress activation 
 proliferation microglia alleviate neuroinflammation 
 contribute visual function restoration ramirez et 
 al. 2017 explore potential role npc-sevs 
 neuroinflammation cx3cr1-gfp transgenic mouse 
 specific gfp labeling microglia perform 
 anti-ionized calcium binding adaptor molecule 1 iba1 
 immunostaining retinal section flat-mount 
 analysis retina immunostaining retinal section 
 show significant reduction number migrated 
 microglia sev-treated retina day 7 day 14 
 ONC Figure 4a b flat-mounted retina cx3cr1-gfp 
 mouse confirm reduce number microglia 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 NEURAL REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025｜591 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 sev-treated retina day 7 paracentral region 
 hipsc-sev-treated retina figure 4c e analysis 
 grid-crossed point microglia reveal suppress 
 microglial activation sev treatment figure 4f 
 determine npc-sevs protect visual function 
 onc mouse conduct flash visual evoke 
 potential analysis quantitatively measure amplitude 
 n1-p1 wave day 7 ONC figure 5a 
 result show amplitude n1-p1 wave 
 significantly restore npc-sev treatment Figure 5B 
 c result suggest npc-sevs mitigate optic nerve 
 injury contribute restoration visual function 
 npc-sevs play neuroprotective role specific 
 mirna delivery 
 sev play important role cell cell communication 
 transport bioactive molecule involve 
 regulation biological process recipient 
 cell mirna enrichment sev play important role 
 pathophysiological process retinal disease mead 
 Tomarev 2020 subsequently perform 
 component mirna analysis high-throughput sequencing 
 hipsc-sevs npc-sevs npc-sevs find 
 total 163 differentially express mirna compare 
 hiPSC-sEVs show volcano plot figure 6a analysis 
 demirnas show mirna classify 
 enriched mainly nervous system-related biological 
 process figure 6b kegg pathway analysis find 
 demirnas involve common neurodegenerative 
 disorder nervous system development- 
 growth-related pathway figure 6c heatmap show 
 demirnas npc-sev hipsc-sev group 
 classify enriched nervous system figure 
 6d mirna 22 mirna attract attention 
 report participate neuroprotection 
 anti-inflammation select 50 
 abundant mirna npc-sevs accord sequence 
 datum total 17 mirna consider neuroprotective 
 abundant npc-sevs identify intersection analysis 
 account 44.49 50 mirna 
 Figure 6E f consequently speculate npc-sevs 
 exhibit neuroprotective effect rgc degeneration 
 mirna delivery 
 Discussion 
 rgc protection regeneration long-term challenge 
 clinical treatment optic neuropathy pathogenesis 
 neurodegenerative disease complex treatment 
 target single gene meet clinical need stem 
 cell therapy advantageous neurodegenerative disease 
 act multiple target hipsc-differentiate 
 npc avoid ethical issue human embryo 
 particle ml ×10 
 6 
 4 
 3 
 2 
 1 
 0 
 F 
 d 
 g 
 e 
 
 c 
 b 
 Diameter nm 
 0   100   200 300 400   500 600 700   800 900 1000 
 cell         sevs 
 32 kda 
 44 kda 
 96 kda 
 90 kda 
 sdcbp 
 tsg101 
 ALIX 
 Calnexin 
 300 × g 
 2000 × g 
 100000 × g 
 100000 × g 
 10000 × g 
 4 ° c 
 10 min 
 4 ° c 
 10 min 
 4 ° c 
 30 min 
 4 ° c 
 70 min 
 4 ° c 
 70 min 
 sevs 
 cell 
 supernatant 
 ipscs 
 d0 
 neuroepithelium 
 d10 
 d14 
 npc 
 ipscs 
 npc 
 Figure 1 ｜isolation characterization 
 sev hipscs hipsc-npcs 
 schematic illustration direct npc 
 differentiation hipscs b c representative 
 morphology immunostaining hipscs 
 hipsc-npcs hipscs show typical 
 clone morphology sox2 tra-1- 
 60 expression hipsc-npc show typical 
 epithelium morphology pax6 nestin 
 expression scale bar 100 μm d schematic 
 sev isolation protocol e Representative 
 TEM image npc-sevs show typical 
 cup-like structure scale bar 200 nm f 
 size distribution npc-sevs inset 
 snapshot image video tracking g western 
 blot result positive sdcbp tsg101 
 ALIX negative calnexin biomarker 
 npc-sevs parental cell alix apoptosis- 
 link gene 2-interacting protein x hipsc 
 human induced pluripotent stem cell nem 
 neural expansion medium nim neural 
 induction medium npc neuronal progenitor 
 cell pax6 pair box 6 sdcbp syndecan 
 binding protein sev small extracellular vesicle 
 sox2 sry-box transcription factor 2 tra-1 60 
 tumor-related antigen-1 60 tsg101 tumor 
 susceptibility 101 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 592   ｜neural REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 Figure 2 ｜neuroprotective effect sev hipscs hipsc-npc oct staining  
 schematic animal experiment b representative oct image mouse 7 14 day post-onc thickness retina decrease 
 time scale bar 200 μm c oct statistical result mean thickness gcc layer n = 16 p < 0.05 p < 0.01 hipsc-sevs group 
 vs. pbs group p < 0.05 p < 0.01 npc-sevs group vs. pbs group d representative image gcc layer mouse 7 14 day 
 post-onc similar result obtain oct thickness retina decrease time scale bar 20 μm e statistical result 
 mean thickness gcc layer n = 12 f quantification mean number cell gcl n = 12 p < 0.05 p < 0.001 datum 
 express mean ± sem c mean ± sd e f analyze Student t-test c one-way analysis variance follow 
 Tukey post hoc test e f gcc ganglion cell complex gcl ganglion cell layer hematoxylin-eosin hipsc human induce pluripotent 
 stem cell immunofluorescence ipsc induce pluripotent stem cell npc neural progenitor cell ns significant oct optical coherence 
 tomography onc optic nerve crush onh optic nerve head pbs phosphate buffer saline sev small extracellular vesicle vep visual evoke 
 potential 
 solve problem find source human neural cell 
 beneficial treatment potential nervous system 
 disorder study show hipsc-npcs promote 
 neuronal protection rgc survival ju Tam 
 2022 transplant cell integrate 
 tissue instead mainly involve secretion 
 neurotrophic factor regulation microenvironment 
 Karagiannis et al. 2019 view focus sev 
 recognize cell-free therapeutic source 
 deliver biomolecule parent cell recipient cell 
 good biocompatibility low immunogenicity previous 
 study show msc-derived sev potential 
 treatment neurodegenerative disease mead et al. 
 2018 Hade et al. 2021 compare mscs ipsc 
 pluripotency npc differentiate cell 
 nervous system reason interested 
 npc-derived sev advantageous 
 neurodegenerative disease therapy 
 study successfully develop hipsc-npc 
 differentiation system obtain high-purity sev cell 
 supernatant find sev cross inner limit 
 membrane internalize ganglion cell layer cell 
 include rgc microglia astrocyte early 48 
 hour intravitreal injection consistent 
 previous study Mathew et al. 2021 find treatment 
 hipsc-npc-sev significantly reduce rgc loss 
 partially restore visual function damage occur 
 neurodegenerative disease degeneration progressive 
 difficult stop maximize therapeutic effect sev 
 treatment perform time injury 
 rgc observable hipsc-npc-sev-treated 
 retina 14 day ONC amplitude flash visual evoke 
 potential decrease low level interestingly 
 hipsc-npc-sev treatment cause significantly potent 
 durable neuroprotective effect compare hipsc-sev 
 treatment report msc play major 
 role paracrine effect cell replacement 
 Andrzejewska et al. 2021 intercellular communication 
 sev play important role nervous system 
 Budnik et al. 2016 alternatively optic nerve lamina 
 region npc niche secrete growth factor promote 
 neuronal extension Bernstein et al. 2020 novel 
 study suggest npc-derived sev transport bioactive 
 molecule parent cell play role rgc neuroprotection 
 consider sev good biocompatibility low 
 immunogenicity allogeneic hipsc- msc-derived npc- 
 sev therapy clinic effectively avoid immune rejection 
 unexpected effect 
 Thickness gcc μm 
 60 
 55 
 50 
 45 
 40 
 c 
 40 
 20 
 0 
 Thickness gcc μm 
 55 
 50 
 45 
 40 
 35 
 30 
 15 
 0 
 Distance ONH μm 
 550 
 500 
 400 
 300 
 200 
 0 
 200 
 300 
 400 
 500 
 550 
 Distance ONH μm 
 550 
 500 
 400 
 300 
 200 
 0 
 200 
 300 
 400 
 500 
 550 
 onc+pbs 
 onc+ipscs sevs 
 onc+npcs sevs 
 onc+pbs 
 onc+ipscs sevs 
 onc+npcs sevs 
 14 d 
 7 d 
 
 
 
 
 
 
 
 
 
 
 Thickness gcc μm 
 80 
 60 
 40 
 20 
 0 
 E 
 Thickness gcc μm 
 80 
 60 
 40 
 20 
 0 
 cell number gcl 
 500 
 400 
 300 
 200 
 100 
 0 
 F 
 cell number gcl 
 500 
 400 
 300 
 200 
 100 
 0 
 7 d 
 14 d 
 7 d 
 14 d 
 
 
 
 ns 
 ns 
 ns 
 ns 
 ns 
 ns 
 ns 
 ns 
 ns 
 d 
 
 b 
 Control 
 onc+pbs 
 onc+ipscs sevs 
 onc+npcs sevs 
 Control 
 onc+pbs 
 onc+ipscs sevs onc+npcs sev 
 7 d 
 14 d 
 7 d 
 14 d 
 Control 
 onc+pbs 
 onc+ipscs sevs 
 onc+npcs sevs 
 oct/vep 
 staining/ flat-mounted retinas/if 
 7 d 
 14 d 
 0 d 
 200 μm 
 20 μm 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 NEURAL REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025｜593 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 Figure 3 ｜ rgc survival onc mouse sev treatment 
 flat-mounted retina onc mouse treatment sev day 7 day 14 post-onc rgc degeneration progressive 
 ONC b schematic diagram different region flat-mounted retina central paracentral peripheral create Microsoft 
 PowerPoint Professional 2019 c representative image central paracentral peripheral retinal region onc model mouse 
 treatment sev follow treatment hipsc-sevs rgc survive retina day 7 post-onc follow 
 treatment npc-sevs rgc survive retina day 7 14 scale bar 100 μm d quantification mean number 
 rgc different retinal region 7 14 day n = 8/group datum express mean ± sd p < 0.05 p < 0.01 p < 0.001 one- 
 way analysis variance follow Tukey post hoc test hipsc human induce pluripotent stem cell ipsc induce pluripotent stem cell 
 npc neural progenitor cell ns significant onc optic nerve crush pbs phosphate buffer saline rgc retinal ganglion cell sev small 
 extracellular vesicle 
 Number rgc 
 200 
 150 
 100 
 50 
 0 
 Central      Paracentral     peripheral 
 
 
 
 
 
 
 
 
 
 7 d 
 d 
 Number rgc 
 200 
 150 
 100 
 50 
 0 
 Central     Paracentral     peripheral 
 
 
 
 
 
 
 ns 
 ns 
 ns 
 14 d 
 Control 
 onc+pbs 
 onc+ipscs-sevs 
 onc+npcs-sevs 
 
 b 
 c 
 Control 
 Control 
 onc+pbs 
 onc+ipscs-sevs onc+npcs-sevs 
 onc+pbs 
 onc+ipscs-sevs onc+npcs-sevs 
 onc+pbs 
 onc+ipscs- 
 sevs 
 onc+npcs- 
 sevs 
 7 d 
 14 d 
 Central 
 Paracentral 
 Peripheral 
 7 d 
 14 d 
 Neuroinflammation central nervous system play 
 essential role protect tissue injury 
 uncontrolle prolonged neuroinflammation lead 
 secondary damage contribute factor 
 neurodegeneration ramirez et al. 2017 sev react neural 
 damage morphological change proliferation migration 
 production inflammatory cytokine 
 propagate neuroinflammation Wei et al. 2019 Microglia 
 principal modulatory cell nervous system include 
 brain retina injury play important role 
 nutrition protection repair damage neuron Mundt 
 et al. 2022 study find hipsc-npc-sevs 
 minimize microglial activation result reconstruction 
 microenvironment benefit rgc survival previously 
 show sev derive primary npc preserve 
 photoreceptor mouse model retinal degeneration 
 inactivating microglia Bian et al. 2020 interestingly report 
 show mscs treat gw4869 inhibitor 
 sev biogenesis suppressive effect glial activation 
 suggest therapeutic role msc neural injury 
 occur sev secretion Deng et al. 2021 
 investigate mechanism hipsc-npc- 
 sev rgc protection numerous study show 
 sev derive stem cell involve 
 neuroprotection transport mirna mead Tomarev 
 2020 consequently sev cargo mirna detect 
 high-throughput sequencing demirnas hipsc-npc- 
 sev analyze compare hiPSC-sEVs 
 find mirna mir-181 mir-9 mir-125b-5p 
 let-7 family report play important 
 role microglial activation neurogenesis bian et al. 
 2020 Fernández et al. 2020 tian et al. 2021 
 mirna mir-122 5p mirna-9 5p mir-218 5p 
 mirna-29 know exert neuroprotective effect 
 Jayaram et al. 2015 Ma et al. 2023 overall upregulate 
 mirna hipsc-npc-sevs enrich neuronal survival 
 neurogenesis-related biological process tnf- mapk- 
 
 neurotrophin- common neurodegenerative disorder- 
 related signaling pathway ding et al. 2022 twenty-two 
 upregulate mirna involve regulation 
 neuroprotection anti-inflammation 17 22 
 50 abundant mirna analysis confirm 
 sev multitarget therapeutic effect retinal 
 cell transportation cargo mirna 
 investigate rgc protection npc-sevs onc mouse 
 target delivery sev optic nerve regeneration 
 rgc axon need investigation role 
 msc-sevs neural protection widely study comparative 
 study msc-sevs npc-sevs essential identify 
 underlying effect mechanism neural protection 
 additionally find combination 17 mirna npc- 
 sev play multitarget therapeutic effect rgc protection 
 optimization mirna complex delivery 
 optimized mirna complex interesting 
 study 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 594   ｜neural REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 Figure 5 ｜protective effect npc-sevs visual function onc mouse    
 schematic diagram fvep create Microsoft PowerPoint Professional 2019 b mean amplitude n1–p1 wave detect 
 fvep day 7 n = 8) datum express mean ± sd p < 0.001 one-way analysis variance follow Tukey post hoc test c 
 overlapping fvep wave onc mouse treatment npc-sevs day 7 fvep Flash visual evoke potential npc neural 
 progenitor cell onc optic nerve crush pbs phosphate buffer saline sev small extracellular vesicle 
 Figure 4 ｜anti-inflammatory effect sev hipscs hipsc-npcs   
 frozen section retina day 7 14 migrated microglia reduce sev-treated retina day 7 day 14 ONC 
 scale bar 50 μm b quantification mean number iba1-positive cell field n = 5 c flat-mounted retina onc cx3cr1-gfp 
 mouse day 7 number microglia increase retina onc decrease sev-treated retina d representative image 
 central paracentral peripheral retinal region onc model cx3cr1-gfp mouse treatment sev day 7 
 number microglia grid-crossed point microglia reduce sev-treated retina day 7 scale bar 100 μm e statistical 
 result mean number microglia cx3cr1-gfp positive cell field different retinal region n = 5 f quantification mean grid- 
 crossed point microglia n = 5 datum express mean ± sd p < 0.05 p < 0.01 p < 0.001 one-way analysis variance 
 follow Tukey post hoc test cx3cr1 cx3c chemokine receptor 1 dapi 4’,6-diamidino-2-phenylindole gfp green fluorescent protein 
 iba1 ionize calcium-binding adapter molecule 1 hipsc human induce pluripotent stem cell ipsc induce pluripotent stem cell npc 
 neural progenitor cell ns significant onc optic nerve crush pbs phosphate buffer saline sev small extracellular vesicle 
 15 
 10 
 5 
 0 
 b 
 Number 
 iba1 
 + cell 
 7 d 
 14 d 
 Control 
 onc+pbs 
 onc+ipsc-sevs 
 onc+ipsc-npc-sevs 
 ns 
 ns 
 
 
 150 
 100 
 50 
 0 
 E 
 Number microgila 
 central       Paracentral    peripheral 
 Control 
 onc+pbs 
 onc+ipsc-sevs 
 onc+npc-sevs 
 
 
 
 
 
 
 
 ns 
 ns 
 30 
 20 
 10 
 0 
 F 
 grid-crossed point 
 
 
 ns 
 Control 
 onc+pbs 
 onc+ipsc-sevs 
 onc+npc-sevs 
 
 Control 
 onc+pbs 
 onc+ipscs-sevs 
 onc+npcs-sevs 
 Control 
 onc+pbs 
 onc+ipscs-sevs 
 onc+npcs-sevs 
 Control 
 onc+pbs 
 onc+ipscs-sevs 
 onc+npcs-sevs 
 14 d 
 7 d 
 c 
 Control 
 onc+pbs 
 onc+ipscs- 
 sevs 
 onc+npcs- 
 sevs 
 d 
 Central          Paracentral        Peripheral 
 25 
 20 
 15 
 10 
 5 
 b 
 5 
 4 
 3 
 2 
 1 
 0 
 n1-p1 amplitude 
 μv 
 Control 
 onc+pbs 
 onc+npc-sevs 
 
 7 d 
 0.00005 
 0 
 –0.00005 
 normalize channel 
 Values v 
 c 
 7 d 
 Control 
 onc+pbs 
 onc+npc-sevs 
 Time s 
 0                         0.05                       0.10 
 
 summary novel study show intravitreous 
 injection hipsc-npc-sevs successfully take 
 retinal cell alleviate rgc degeneration suppress 
 microglial activation contribute visual function 
 restoration optic nerve injury additionally multitarget 
 regulation neuroretinal protection inflammatory 
 microenvironment bioactive mirna potential 
 therapeutic mechanism hipsc-npc-sevs finding 
 suggest hipsc-npc-sevs promising cell-free 
 biological therapeutic strategy treatment optic 
 neuropathy 
 Author contribution study design zlc tl experimental 
 implementation datum collection analysis tl hmx hdq qg slx 
 HM manuscript draft tl hmx zlc author review approve 
 final version manuscript 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 NEURAL REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025｜595 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 
 b 
 d 
 c 
 e 
 F 
 Figure 6 ｜mirna sequencing analysis 
 sev derive hipscs npc 
 Volcano plot differentially express 
 mirna hipsc-sevs npc-sevs b c 
 kegg pathway enrichment analysis 
 differentially express mirna d heatmap 
 differentially express mirna related 
 neural pathway e expression rank 
 mirna npc-sevs f pie chart show 
 percentage 17 neuroprotective mirna 
 50 mirna term expression 
 DEG differentially express gene gene 
 ontology hipsc human induce pluripotent 
 stem cell kegg Kyoto Encyclopedia gene 
 Genomes mirna microrna npc neural 
 progenitor cell sev small extracellular vesicle 
 TPM tag million 
 conflict interest author declare compete interest 
 data availability statement   datum generate analyze 
 study include publish article additional file 
 open access statement open access journal article 
 distribute term Creative Commons Attribution- 
 noncommercial-sharealike 4.0 License allow remix 
 tweak build work non-commercially long appropriate 
 credit give new creation license identical 
 term 
 open peer reviewer Alicia Mansilla Universidad de Alcala Spain 
 additional file 
 additional Figure 1 number distribution mouse experiment 
 additional Figure 2 internalization sev retinal cell 
 additional Table 1 antibody study 
 additional file 1 open peer review report 1 
 reference 
 Ahmed M Kojima Y Masai 2022 strip1 regulate retinal ganglion cell 
 survival suppress jun-mediated apoptosis promote retinal 
 neural circuit formation elife 11:e74650 
 Andrzejewska Dabrowska S Lukomska b Janowski M 2021 
 mesenchymal stem cell neurological disorder Adv Sci Weinh 
 8:2002944 
 Association Research Vision Ophthalmology 2021 ARVO 
 Statement Use Animals Ophthalmic Vision Research 
 Baloh rh et al. 2022 transplantation human neural progenitor cell 
 secreting gdnf spinal cord patient als phase 1/2a 
 trial nat Med 28:1813 1822 
 Bernstein sl Guo Y Kerr c Fawcett RJ stern jh Temple S Mehrabian Z 
 2020 optic nerve lamina region neural progenitor cell niche 
 Proc Natl Acad Sci U S 117:19287 19298 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 596   ｜neural REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 Bian b Zhao c X Gong y ren c Ge L Zeng Y Li Q Chen M Weng 
 c J Fang Y Xu h Yin ZQ 2020 Exosomes derive neural 
 progenitor cell preserve photoreceptor retinal degeneration 
 inactivate microglia j Extracell Vesicles 9:1748931 
 Budnik V ruiz-cañada c Wendler F 2016 extracellular vesicle round 
 communication nervous system nat rev Neurosci 17:160- 
 172 
 Cameron EG Xia X Galvao J Ashouri M Kapiloff ms Goldberg JL 2020 
 Optic nerve crush mouse study retinal ganglion cell survival 
 regeneration bio protoc 10:e3559 
 Channon lm tyma vm Xu Z Greening DW Wilson JS Perera CJ Apte 
 MV 2022 small extracellular vesicle exosome cargo 
 pancreatic cancer key role hallmark cancer biochim 
 Biophys Acta Rev Cancer 1877:188728 
 Chong MC Silva James PF Wu SSX Howitt J 2022 exercise increase 
 release NAMPT extracellular vesicle alter nad(+ 
 activity recipient cell aging cell 21:e13647 
 Cui y Liu C Huang L Chen J Xu N 2021 protective effect intravitreal 
 administration mesenchymal stem cell-derived exosome 
 experimental model optic nerve injury exp cell res 407:112792 
 Deng CL Hu CB ling ST Zhao N Bao LH Zhou F Xiong yc Chen t Sui BD 
 Yu XR Hu CH 2021 photoreceptor protection mesenchymal stem 
 cell transplantation identify exosomal MiR-21 therapeutic 
 retinal degeneration cell death differ 28:1041 1061 
 ding c Wu Y Dabas H Hammarlund M 2022 activation 
 camkii-sarm1-ask1-p38 map kinase pathway protect axon 
 degeneration cause loss mitochondria elife 11:e73557 
 ding y Li Y Sun Z Han X Chen Y Ge Y Mao Z Wang W 2021 cell- 
 derive extracellular vesicle membrane tissue repair j 
 Nanobiotechnology 19:368 
 Fernández V Martínez-Martínez M Prieto-Colomina Cárdenas Soler 
 r Dori M Tomasello U Nomura y López-Atalaya jp Calegari F Borrell 
 V 2020 repression irs2 let-7 mirna essential homeostasis 
 telencephalic neuroepithelium embo j 39:e105479 
 Fischer Dulin JN Lane MA 2020 transplant neural progenitor 
 cell restore connectivity spinal cord injury nat rev Neurosci 
 21:366 383 
 Friedländer MR Mackowiak sd Li N Chen W Rajewsky N 2012 
 mirdeep2 accurately identify know hundred novel 
 microrna gene seven animal clade nucleic acid Res 40:37 52 
 Fu h Siggs OM knight ls Staffieri se Ruddle JB Birsner AE collante 
 er Craig JE Wiggs JL d’amato rj 2022 thrombospondin 1 missense 
 allele induce extracellular matrix protein aggregation tm 
 dysfunction congenital glaucoma j Clin Invest 132:e156967 
 Gandham S Su X Wood J Nocera AL Alli SC Milane L Zimmerman 
 Amiji M ivanov AR 2020 technology standardization 
 research extracellular vesicle trend biotechnol 38:1066 1098 
 Gokoffski kk Lam p Alas BF Peng MG Ansorge HRR 2020 Optic nerve 
 regeneration J Neuroophthalmol 40:234 242 
 Goldman SA 2016 stem progenitor cell-based therapy 
 central nervous system hope hype wishful thinking cell stem 
 cell 18:174 188 
 Griffiths-Jones S Grocock RJ van Dongen S Bateman Enright aj 2006 
 mirbase microrna sequence target gene nomenclature 
 Nucleic Acids Res 34:d140 144 
 Guo X Zhou J Starr C Mohns ej Li Y Chen EP Yoon y Kellner cp Tanaka 
 K Wang H Liu W Pasquale LR Demb JB Crair MC Chen b 2021 
 Preservation vision camkii-mediated protection retinal 
 ganglion cell cell 184:4299 4314.e12 
 Gurunathan S Kang MH Jeyaraj M Qasim M Kim jh 2019 review 
 isolation characterization biological function multifarious 
 therapeutic approach exosome cell 8:307 
 hade md suire cn suo z 2021 mesenchymal stem cell-derived 
 exosome application regenerative medicine cell 10:1959 
 hu t Meng S Zhang Q Song S Tan c Huang J Chen D 2022 astrocyte 
 derive tsp2 contribute synaptic alteration visual dysfunction 
 retinal ischemia/reperfusion injury cell Biosci 12:196 
 Huang J U KP Yang F Ji Z Lin J Weng Z Tsang LL Merson TD Ruan 
 yc Wan C Li g Jiang X 2022 human pluripotent stem cell-derived 
 ectomesenchymal stromal cell promote robust functional 
 recovery umbilical cord-derived mesenchymal stromal cell 
 hypoxic-ischaemic brain damage theranostic 12:143 166 
 Huang L Zhang L 2019 neural stem cell therapy hypoxic-ischemic 
 brain injury prog Neurobiol 173:1 17 
 ito d Morimoto S Takahashi S Okada K Nakahara J Okano h 2023 
 Maiden voyage induce pluripotent stem cell-based drug screening 
 amyotrophic lateral sclerosis brain 146:13 19 
 Jayaram H Cepurna WO Johnson EC morrison jc 2015 microrna 
 expression glaucomatous retina invest Ophthalmol Vis Sci 
 56:7971 7982 
 Jiang D Xiong g Feng H Zhang Z Chen p Yan b Chen L Gandhervin K 
 Ma c Li C Han S Zhang Y Liao C Lee tl Tse HF Fu QL Chiu K Lian Q 
 2019 donation mitochondria ipsc-derived mesenchymal stem 
 cell protect retinal ganglion cell mitochondrial complex 
 defect-induced degeneration theranostic 9:2395 2410 
 ju Y Tam KY 2022 pathological mechanism therapeutic strategy 
 Alzheimer disease neural Regen Res 17:543 549 
 Kalluri R LeBleu VS 2020 biology function biomedical 
 application exosome science 367:eaau6977 
 Kalvari Nawrocki EP ontiveros-palacios n Argasinska J Lamkiewicz K 
 Marz M Griffiths-Jones S toffano-nioche c Gautheret D Weinberg 
 Z Rivas E Eddy SR Finn RD Bateman Petrov ai 2021 Rfam 14 
 expand coverage metagenomic viral microrna family 
 Nucleic Acids res 49:d192-d200 
 Karagiannis p Takahashi K Saito M Yoshida Y Okita K Watanabe 
 Inoue h Yamashita JK Todani M Nakagawa M Osawa M Yashiro y 
 Yamanaka S Osafune K 2019 induced pluripotent stem cell 
 use human model disease development physiol rev 99:79- 
 114 
 Kechin Boyarskikh U Kel Filipenko M 2017 cutprimer new tool 
 accurate cutting primer read target generation 
 sequencing j Comput Biol 24:1138 1143 
 Kerschensteiner d 2022 feature detection retinal ganglion cell 
 Annu Rev Vis Sci 8:135 169 
 Kirkeby Nelander J Parmar M 2012 generating regionalize neuronal 
 cell pluripotency step-by-step protocol Cell Neurosci 
 6:64 
 langmead b salzberg sl 2012 fast gapped-read alignment Bowtie 
 2 nat method 9:357 359 
 Liu L Michowski W Kolodziejczyk Sicinski p 2019 cell cycle 
 stem cell proliferation pluripotency differentiation nat cell Biol 
 21:1060 1067 
 Liu Z Xue J Liu C Tang J Wu S Lin J Han J Zhang Q Wu C Huang H 
 Zhao L Zhuo Y Li y 2023 selective deletion zinc transporter 3 
 amacrine cell promote retinal ganglion cell survival optic nerve 
 regeneration injury neural Regen Res 18:2773 2780 
 love MI Huber W Anders S 2014 moderated estimation fold change 
 dispersion rna-seq datum deseq2 genome biol 15:550 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
 NEURAL REGENERATION RESEARCH｜Vol 20｜No 2｜february 2025｜597 
 NEURAL REGENERATION research 
 www.nrronline.org 
 Research Article 
 Ma zx Liu Z Xiong hh Zhou ZP Ouyang ls Xie FK Tang YM Wu ZD 
 Feng Y 2023 micrornas protective regulator neuron growth 
 development neural Regen Res 18:734 745 
 Mathew b Torres LA Gamboa Acha L Tran S Liu Patel r 
 Chennakesavalu M Aneesh Huang CC Feinstein DL Mehraeen S 
 Ravindran S Roth S 2021 uptake distribution administer 
 bone marrow mesenchymal stem cell extracellular vesicle retina 
 cell 10:730 
 mead b Tomarev S 2017 bone marrow-derived mesenchymal stem 
 cells-derived exosome promote survival retinal ganglion cell 
 mirna-dependent mechanism stem cell Transl Med 
 6:1273 1285 
 mead b Tomarev S 2020 extracellular vesicle therapy retinal 
 disease prog Retin Eye Res 79:100849 
 mead b Amaral J Tomarev S 2018 mesenchymal stem cell-derived 
 small extracellular vesicle promote neuroprotection rodent model 
 glaucoma invest Ophthalmol Vis Sci 59:702 714 
 Mundt S Greter M Becher b 2022 cns mononuclear phagocyte 
 system health disease neuron 110:3497 3512 
 Nakano N Ikeda HO Hangai M muraoka y Toda Y Kakizuka Yoshimura 
 n 2011 longitudinal simultaneous imaging retinal ganglion 
 cell inner retinal layer mouse model glaucoma induce 
 n-methyl-d-aspartate invest Ophthalmol Vis Sci 52:8754 8762 
 Newman NJ yu-wai-man p Biousse V Carelli v 2023 understand 
 molecular basis pathogenesis hereditary optic neuropathy 
 improve diagnosis management lancet neurol 22:172- 
 188 
 pan D Chang X Xu M Zhang M Zhang S Wang Y Luo X Xu J Yang X 
 Sun X 2019 umsc-derived exosome promote retinal ganglion cell 
 survival rat model optic nerve crush j Chem Neuroanat 96:134- 
 139 
 Ramirez ai de Hoz R salobrar-garcia e salazar jj rojas b Ajoy d lópez- 
 Cuenca rojas p Triviño Ramírez JM 2017 role microglia 
 retinal neurodegeneration alzheimer disease Parkinson 
 glaucoma Aging Neurosci 9:214 
 Rong R Zhou X Liang g Li H M Liang Z Zeng Z Xiao h Ji D Xia 
 X 2022 target cell membrane deplete ros dithiane 
 thioketal-containing polymer pendant cholesterol deliver 
 necrostatin-1 glaucoma treatment acs nano 16:21225 21239 
 Schneider Rasband WS eliceiri kw 2012 NIH Image imagej 25 
 year image analysis nat method 9:671 675 
 sheller-miller S Trivedi J Yellon SM Menon r 2019 exosome cause 
 preterm birth mouse evidence paracrine signaling pregnancy 
 Sci Rep 9:608 
 Shi Y Wang Y Li Q Liu K Hou J Shao c Wang y 2018 immunoregulatory 
 mechanism mesenchymal stem stromal cell inflammatory 
 disease nat rev nephrol 14:493 507 
 Strnadel J et al. 2018 survival syngeneic allogeneic ipsc-derived 
 neural precursor spinal grafting minipig Sci Transl Med 
 10:eaam6651 
 Sugimoto N et al. 2022 iplat1 first-in-human clinical trial ipsc- 
 derive platelet phase 1 autologous transfusion study blood 
 140:2398 2402 
 tian t Cao L c ye Q Liang R W Zhang H Wu J Ye J tannous 
 BA Gao J 2021 target delivery neural progenitor cell-derived 
 extracellular vesicle anti-inflammation cerebral ischemia 
 theranostic 11:6507 6521 
 Van Gelder RN Chiang MF Dyer MA Greenwell TN Levin LA Wong ro 
 Svendsen cn 2022 regenerative restorative medicine eye 
 disease nat Med 28:1149 1156 
 Wang Z Wiggs JL Aung t Khawaja AP Khor cc 2022a genetic basis 
 adult onset glaucoma recent advance future direction prog 
 Retin Eye res 90:101066 
 Wang ZB Wang ZT Sun Y Tan L yu jt 2022b future stem cell 
 therapy alzheimer disease ageing res rev 80:101655 
 Wei X Cho ks Thee EF Jager MJ Chen df 2019 Neuroinflammation 
 microglia glaucoma time paradigm shift j Neurosci Res 
 97:70 76 
 Xue y Cai X Wang L Liao b Zhang H Shan Y Chen Q zhou t Li X Hou J 
 Chen S Luo R Qin D Pei d pan g 2013 generate non-integrating 
 human induced pluripotent stem cell bank urine-derived cell 
 plos 8:e70573 
 Yamanaka S 2020 pluripotent stem cell-based cell therapy-promise 
 challenge cell stem cell 27:523 531 
 Yokobayashi S Yabuta Y Nakagawa M Okita K Hu b murase y Nakamura 
 t bourque g Majewski J Yamamoto t Saitou M 2021 inherent 
 genomic property underlie epigenomic heterogeneity human 
 induced pluripotent stem cell cell rep 37:109909 
 yu g Wang LG Han Y qy 2012 clusterprofiler r package 
 compare biological theme gene cluster omics 16:284 287 
 Yuan S Stewart KS Yang Y Abdusselamoglu MD Parigi SM Feinberg 
 ty Tumaneng K Yang H Levorse JM Polak L Ng D Fuchs E 
 2022 ras drive malignancy stem cell crosstalk 
 microenvironment nature 612:555 563 
 Zhang CL Liu JC zhou wj Yu YZ Tang CC Zou XL Zou YP 2023 
 protective effect stem cell retinal ganglion cell regeneration 
 Zhongguo Zuzhi Gongcheng Yanjiu 27:1593 1602 
 p-reviewer Mansilla c-editor Zhao m s-editor Yu J Li CH 
 l-editor Yu J Song lp t-editor Jia Y 
 Downloaded http://journals.lww.com/nrronline bhdmf5ephkav1zeoum1tqfn4a+kjlhezgbsiho4xmi0hcyw 
 cx1awnyqp/ilqrhd3i3d0odryi7tvsfl4cf3vc1y0abggqzxdggj2mwlzlei= 06/01/2024 
